Hydrix Medical

AI & Smart Technologies Managing Cardiovascular Disease

*These products are not available for purchase by the general public.

Hydrix Medical

Hydrix Medical is committed to releasing breakthrough, technology-rich products, helping patients and medical professionals overcome cardiovascular health challenges.

Our team provides cutting-edge solutions that enhance the diagnosis, treatment, and management of CVD. We believe that by leveraging advanced cardiovascular technology, we can transform how CVD is managed, leading to improved patient care and outcomes. Our products are technologically advanced, user-friendly, and practical, tailored to the unique needs of patients and healthcare providers.

Hydrix Medical’s mission is to bring to market medical products that help overcome cardiovascular healthcare challenges.

Breakthrough technology for enhanced cardiovascular care

Implicity
Applying AI to transform the landscape of cardiac remote monitoring.

AI-driven, this RM solution delivers a complete and accurate cardiovascular monitoring technology and data management tool that effectively supports health professionals in the diagnosis, rehabilitation and surveillance of their cardiovascular patients.

EchoSolv a cloud-based decision support software | Speak to Hydrix for a demo
AI-powered technology to enhance the diagnosis of structural heart disease.

ECHOSolv is a cloud-based platform is backed by the latest in medical technology, AI, and machine learning. This innovative decision-support tool is designed to highlight probability indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound.

GUARDIAN the world's first and only heart attack warning system
The first and only FDA-approved heart-attack warning system.

Avertix Guardian™ – the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks improving symptom to door time and reducing treatment delays.

Cardiovascular Disease (CVD) is the world’s leading cause of death and places a significant burden on global healthcare systems. In 2019 it was the cause of one-third of all deaths globally and this number continues to rise.

Hydrix Medicals’ mission is to help tackle the global CVD crisis through the marketing and distribution of innovative CVD technologies and products that will transform lives.